The aim of this study was to evaluate specific glutathione S-transferase (GST) gene variants as determinants of risk in patients with clear cell renal cell carcinoma (cRCC), independently or simultane
High-throughput genomic technologies yield about 20,000 variants in the protein-coding exome of each individual. A commonly used approach to select candidate disease-causing variants is to test whethe
Abbreviations: CI: confidence interval; OR: odds ratio; number: literature number; CAD size: the total number of CAD cases; Con size: control group size, the total number of control group; *P<0.05.
